Case report: high-dose intravenous immunoglobulin as therapy for thrombotic thrombocytopenic purpura.
Thrombotic thrombocytopenic purpura is a clinical syndrome defined by the pentad of thrombocytopenia, microangiopathic hemolytic anemia, fever, and renal and neurologic abnormalities. The pathogenesis of this syndrome remains enigmatic, though appropriate management usually involves plasma administration. The authors report on an alternative therapy, high-dose intravenous immunoglobulin, used in the patient after the failure of plasmapheresis. The implications and potential applications of this therapy are discussed.
Kolodziej
M
M
Hematology-Oncology Section, Hospital of the University of Pennsylvania, Philadelphia.
D000328:Adult; D004334:Drug Administration Schedule; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D010956:Plasmapheresis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy*
D016756:Immunoglobulins, Intravenous